RETRACTED: Nanotechnology for Healthcare: Plant-Derived Nanoparticles in Disease Treatment and Regenerative Medicine.

Fuente: PubMed
Saved in:
Bibliographic Details
Main Authors: Karnwal, Arun, Jassim, Amar Yasser, Mohammed, Ameer Abbas, Sharma, Vikas, Al-Tawaha, Abdel Rahman Mohammad Said, Sivanesan, Iyyakkannu
Format: Artículo científico
Language:en
Published: Pharmaceuticals (Basel, Switzerland) 2024
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266258160418818
author Karnwal, Arun
Jassim, Amar Yasser
Mohammed, Ameer Abbas
Sharma, Vikas
Al-Tawaha, Abdel Rahman Mohammad Said
Sivanesan, Iyyakkannu
author_facet Karnwal, Arun
Jassim, Amar Yasser
Mohammed, Ameer Abbas
Sharma, Vikas
Al-Tawaha, Abdel Rahman Mohammad Said
Sivanesan, Iyyakkannu
Karnwal, Arun
Jassim, Amar Yasser
Mohammed, Ameer Abbas
Sharma, Vikas
Al-Tawaha, Abdel Rahman Mohammad Said
Sivanesan, Iyyakkannu
collection PubMed - marine biology
contents RETRACTED: Nanotechnology for Healthcare: Plant-Derived Nanoparticles in Disease Treatment and Regenerative Medicine. Karnwal, Arun Jassim, Amar Yasser Mohammed, Ameer Abbas Sharma, Vikas Al-Tawaha, Abdel Rahman Mohammad Said Sivanesan, Iyyakkannu Nanotechnology has revolutionised biomedical research, offering innovative healthcare solutions. Plant-based nanotechnology is emerging as a sustainable alternative, minimising environmental impacts and enhancing therapeutic effectiveness. This paper explores the potential of plant-derived nanoparticles (PNPs) in medicine, highlighting their biocompatibility, multifunctionality, and eco-friendliness. PNPs, synthesised through green methods, have demonstrated promising applications in drug delivery, cancer therapy, antimicrobial treatments, and tissue regeneration. Their unique properties, such as a high surface area and bioactive components, enable improved drug delivery, targeting, and controlled release, reducing side effects and enhancing treatment efficacy. Additionally, plant-derived compounds' inherent antimicrobial and antioxidant properties, retained within platinum nanoparticles (PNPs), present innovative opportunities for combating antimicrobial resistance and promoting wound healing. Despite their potential, challenges remain in standardising PNP synthesis, ensuring consistency, and scaling up production for industrial applications. This review emphasises the need for further research on PNP toxicity, biocompatibility, and regulatory frameworks to fully harness their capabilities in clinical and commercial applications. Plant-based nanotechnology represents a promising, greener alternative for advancing healthcare solutions, aligning with global sustainability goals.
format Artículo científico
id pubmed_39770553
institution PubMed
language en
publishDate 2024
publisher Pharmaceuticals (Basel, Switzerland)
record_format pubmed
spellingShingle RETRACTED: Nanotechnology for Healthcare: Plant-Derived Nanoparticles in Disease Treatment and Regenerative Medicine.
Karnwal, Arun
Jassim, Amar Yasser
Mohammed, Ameer Abbas
Sharma, Vikas
Al-Tawaha, Abdel Rahman Mohammad Said
Sivanesan, Iyyakkannu
RETRACTED: Nanotechnology for Healthcare: Plant-Derived Nanoparticles in Disease Treatment and Regenerative Medicine. Karnwal, Arun Jassim, Amar Yasser Mohammed, Ameer Abbas Sharma, Vikas Al-Tawaha, Abdel Rahman Mohammad Said Sivanesan, Iyyakkannu Nanotechnology has revolutionised biomedical research, offering innovative healthcare solutions. Plant-based nanotechnology is emerging as a sustainable alternative, minimising environmental impacts and enhancing therapeutic effectiveness. This paper explores the potential of plant-derived nanoparticles (PNPs) in medicine, highlighting their biocompatibility, multifunctionality, and eco-friendliness. PNPs, synthesised through green methods, have demonstrated promising applications in drug delivery, cancer therapy, antimicrobial treatments, and tissue regeneration. Their unique properties, such as a high surface area and bioactive components, enable improved drug delivery, targeting, and controlled release, reducing side effects and enhancing treatment efficacy. Additionally, plant-derived compounds' inherent antimicrobial and antioxidant properties, retained within platinum nanoparticles (PNPs), present innovative opportunities for combating antimicrobial resistance and promoting wound healing. Despite their potential, challenges remain in standardising PNP synthesis, ensuring consistency, and scaling up production for industrial applications. This review emphasises the need for further research on PNP toxicity, biocompatibility, and regulatory frameworks to fully harness their capabilities in clinical and commercial applications. Plant-based nanotechnology represents a promising, greener alternative for advancing healthcare solutions, aligning with global sustainability goals.
title RETRACTED: Nanotechnology for Healthcare: Plant-Derived Nanoparticles in Disease Treatment and Regenerative Medicine.
url https://pubmed.ncbi.nlm.nih.gov/39770553/